Andrews Zwilling Consulting
Drug discovery and development consulting.
Scientific clarity. Strategic direction. Confident decisions.
Supporting neuroscience drug discovery teams with translational insight, practical strategy, and disciplined program and project leadership.
What we do.
Andrews Zwilling Consulting strengthens preclinical and translational drug discovery by combining scientific depth with practical, organized execution. We help teams make confident decisions, design rigorous studies, and maintain alignment across science, strategy, and operations.
Why work with Andrews Zwilling Consulting?
Deep pharma and biotech experience across neuroscience, in vivo pharmacology, biomarkers, translational research and clinical trial design and execution.
Hands‑on project management that keeps programs moving, organized, and decision‑ready.
Clear communication tailored to scientists, executives, and external partners.
Vendor‑ready expertise for CRO selection, oversight, and troubleshooting.
A steady, reliable partner who brings structure, clarity, and momentum to complex programs.
Who we are.
-
Co-Founder and Principal Consultant,
Yaisa Andrews Zwilling, PhD, is a neuroscientist with over two decades of experience across preclinical, translational, and clinical research.
Trained at the International Max Planck Research School in Goettingen, Germany and further refined through postdoctoral training at UCSF / J. David Gladstone Institutes, she brings extensive biotech experience and cross‑functional drug‑development strategy expertise across multiple therapeutic areas.
She further strengthened her strategic and business acumen through MIT xPRO’s Drug and Medical Device Development: A Strategic Approach program and the Northwestern Kellogg School of Management’s Business for Scientists and Engineers program.
-
Co-Founder and Principal Consultant
Daniel Zwilling, PhD, is a molecular biologist/neuroscientist and project leader with two decades of experience in academia, pharma and biotech, integrating deep preclinical drug discovery and translational research expertise with structured execution.
His scientific foundation includes training at the International Max Planck Research School in Goettingen, Germany, and UCSF / J. David Gladstone Institutes.
He holds Project Management Professional (PMP) certification with specialized training in Biotechnology Project Management from the University of Washington, as well as Agile Certified Practitioner (PMI‑ACP) certification supported by Agile Project Management training from UC Berkeley—credentials that strengthen his ability to lead complex preclinical and translational programs with operational clarity.
What we bring to the table.
Translational Strategy
Mechanistic and biological rationale development
Biomarker strategy and feasibility assessment
Model selection and translational alignment
Go/no‑go criteria and decision frameworks
Project Management
Program planning and milestone mapping
Cross‑functional coordination
Risk identification and mitigation
Meeting facilitation and documentation
Executive‑ready communication
CRO Management
CRO identification and selection
RFP development and contract negotiation
Study oversight and troubleshooting
Data review and quality control
Vendor relationship management
Study Design & Scientific Support
Pre-clinical
in vivo and in vitro study design
Protocol development
Statistical and experimental planning
Data interpretation and next‑step recommendations
Clinical
Study design
Protocol development
Data interpretation
Scientific storytelling for investors and partners
Let’s move your program forward.
We work with biotech, pharma, academic groups, and research organizations at all stages of discovery and development.